Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 10, 2015 (12 years ago)

ESTRIOL (weight/volume)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

ESTRIOL (E3) W/V (weight/volume) VERSABASE [4714] 0.05% (0.5MG/ML) transdermal cream, dispensed in a) 1 mL and b) 3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Drug: Estriol

Recalling firm
the Compounder
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0224-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Estriol recalls

See all
Class II · Moderate risk

Estriol 1mg/gm

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Terminated cGMP deviation Wedgewood Village Pharmacy, LLC D-1186-2022
Class II · Moderate risk

Estriol 1mg/gm

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Terminated cGMP deviation Wedgewood Village Pharmacy, LLC D-1185-2022
Class II · Moderate risk

Estriol 8 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1421-2020
Class II · Moderate risk

Estriol 6 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1420-2020

Other recalls by the Compounder

All 2015 recalls
Class II · Moderate risk

Triest 80/10/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0228-2016
Class II · Moderate risk

Triest 80/10/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0227-2016
Class II · Moderate risk

Triest 70/20/10

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0226-2016
Class II · Moderate risk

Estriol 5 Estradiol

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0225-2016